Gwenn M. Hansen
Equibles does not estimate personal net worth.
Get an email with a short summary when Nurix Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get NRIX alertsAbout Gwenn M. Hansen
The proxy statement of Nurix Therapeutics, Inc. reports total compensation of $2,498,124 for Gwenn M. Hansen in fiscal 2025, including a base salary of $556,000. Disclosed compensation is on record for 7 fiscal years. Nurix Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Nurix Therapeutics, Inc. includes Arthur T. Sands (CEO and Board Member), Hans van Houte (CFO), Stefani Wolff (COO) and 7 others.
Affiliation history
-
Nurix Therapeutics, Inc. (NRIX)
Proxy statement
CurrentStart not stated–present
Last confirmed March 27, 2026
Company network
Leadership on record at Nurix Therapeutics, Inc.
- Arthur T. Sands CEO, Board Member
- Hans van Houte CFO
- Stefani Wolff COO
- Christine Ring General Counsel
- Anil Kapur Board Member
- Edward C. Saltzman Board Member
- Judith A. Reinsdorf Board Member
- Paul M. Silva Board Member
- Roger Dansey, M.D. Board Member
- Roy D. Baynes, MB.Bch., M.Med., Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | $556,000 | $2,498,124 |
| 2024 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | $510,533 | $2,033,860 |
| 2023 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | $493,200 | $1,632,757 |
| 2022 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | $476,250 | $3,824,583 |
| 2021 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | $433,750 | $2,303,328 |
| 2020 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | $391,250 | $1,552,577 |
| 2019 | Nurix Therapeutics, Inc. (NRIX) | Chief Scientific Officer | $299,167 | $695,404 |
Recent activity
No call appearances or filed executive changes recorded yet.